Evaluation of Outcome of Intravenous Catheter-related  Infections in Critically Ill Patients

Rello, Jordi; Ochagavía, A.; Sabanes, Elena; Figuls, Marta Roqué i; Mariscal, Dolors; Reynaga, Esteban; Vallès, Jordi

doi:10.1164/ajrccm.162.3.9911093

Cited by 316 publications

(188 citation statements)

References 18 publications

Supporting

Mentioning

168

Contrasting

Unclassified

Order By: Relevance

“…No excess mortality 24,25,[32][33][34][35] and dramatic mortality and 103 nonexposed subjects. Table 2 summarizes the characteristics of the exposed and nonexposed groups.…”

Section: Discussionmentioning

confidence: 99%

Morbidity and Mortality of Bloodstream Infections in Patients With Severe Burn Injury

Brusselaers¹,

Monstrey²,

snoeij³

et al. 2010

American Journal of Critical Care

View full text Add to dashboard Cite

“…No excess mortality 24,25,[32][33][34][35] and dramatic mortality and 103 nonexposed subjects. Table 2 summarizes the characteristics of the exposed and nonexposed groups.…”

Section: Discussionmentioning

confidence: 99%

Morbidity and Mortality of Bloodstream Infections in Patients With Severe Burn Injury

Brusselaers¹,

Monstrey²,

snoeij³

et al. 2010

American Journal of Critical Care

View full text Add to dashboard Cite

“…Recent studies suggest that if adjustments are made for the patient's health state before infection, then the attributable mortality risk may be smaller than is currently assumed. 89 In any good quality economic evaluation the reference case rate will be varied within the sensitivity analysis.…”

Section: Attributable Mortalitymentioning

confidence: 99%

“…Anticipated savings are related to the number of CVCs inserted in specific patient groups per year. Only the results of the Spanish study appear to be somewhat cautious; Rello and colleagues 89 conclude that catheter-related infections lead to increased costs and that the potential economic benefits of new techniques to prevent intravascular catheter-related infections need to be explored.…”

Section: Potential Savings From Preventing Crbsismentioning

confidence: 99%

The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation

Hockenhull¹,

Dwan²,

Boland³

et al. 2008

Health Technol Assess

View full text Add to dashboard Cite

Non-UK purchasers will have to pay a small fee for post and packing. For European countries the cost is £2 per monograph and for the rest of the world £3 per monograph.You can order HTA monographs from our Despatch Agents:-fax (with credit card or official purchase order) -post (with credit card or official purchase order or cheque) -phone during office hours (credit card only).Additionally the HTA website allows you either to pay securely by credit card or to print out your order and then post or fax it. NHS libraries can subscribe free of charge. Public libraries can subscribe at a very reduced cost of £100 for each volume (normally comprising 30-40 titles). The commercial subscription rate is £300 per volume. Please see our website for details. Subscriptions can only be purchased for the current or forthcoming volume. Contact details are as follows: Payment methods Paying by chequeIf you pay by cheque, the cheque must be in pounds sterling, made payable to Direct Mail Works Ltd and drawn on a bank with a UK address. Paying by credit cardThe following cards are accepted by phone, fax, post or via the website ordering pages: Delta, Eurocard, Mastercard, Solo, Switch and Visa. We advise against sending credit card details in a plain email. Paying by official purchase orderYou can post or fax these, but they must be from public bodies (i.e. NHS or universities) within the UK. We cannot at present accept purchase orders from commercial companies or from outside the UK. How do I get a copy of HTA on CD?Please use the form on the HTA website (www.hta.ac.uk/htacd.htm). Or contact Direct Mail Works (see contact details above) by email, post, fax or phone. HTA on CD is currently free of charge worldwide.The website also provides information about the HTA Programme and lists the membership of the various committees. HTA NIHR Health Technology Assessment ProgrammeT he Health Technology Assessment (HTA) Programme, part of the National Institute for Health Research (NIHR), was set up in 1993. It produces high-quality research information on the effectiveness, costs and broader impact of health technologies for those who use, manage and provide care in the NHS. 'Health technologies' are broadly defined as all interventions used to promote health, prevent and treat disease, and improve rehabilitation and long-term care. The research findings from the HTA Programme directly influence decision-making bodies such as the National Institute for Health and Clinical Excellence (NICE) and the National Screening Committee (NSC). HTA findings also help to improve the quality of clinical practice in the NHS indirectly in that they form a key component of the 'National Knowledge Service'. The HTA Programme is needs-led in that it fills gaps in the evidence needed by the NHS. There are three routes to the start of projects. First is the commissioned route. Suggestions for research are actively sought from people working in the NHS, the public and consumer groups and professional bodies such as royal colleges and NHS trusts. These sugges...

show abstract

“…If the average rate of CVC-associated BSIs is 5.3 per 1,000 catheter days in the ICU [3], approximately 80,000 CVC-associated BSIs occur in ICUs each year in the United States. The attributable mortality for these BSIs has ranged from no increase in mortality in studies that controlled for severity of illness [4][5][6], to 35% increase in mortality in prospective studies that did not use this control [7,8]. Thus, the attributable mortality remains unclear.…”

Section: Introductionmentioning

confidence: 99%

“…Thus, the attributable mortality remains unclear. The attributable cost per infection is an estimated $34,508-$56,000 [5,9], and the annual cost of caring for patients with CVC-associated BSIs ranges from $296 million to $2.3 billion [10].…”

Section: Introductionmentioning

confidence: 99%

Guidelines for the prevention of intravascular catheter-related infections

O’Grady¹,

Alexander²,

Dellinger³

et al. 2002

American Journal of Infection Control

635

843

View full text Add to dashboard Cite

These guidelines have been developed for practitioners who insert catheters and for persons responsible for surveillance and control of infections in hospital, outpatient, and home health-care settings. This report was prepared by a working group comprising members from professional organizations representing the disciplines of critical care medicine, infectious diseases, health-care infection control, surgery, anesthesiology, interventional radiology, pulmonary medicine, pediatric medicine, and nursing. The These guidelines are intended to provide evidencebased recommendations for preventing catheter-related infections. Major areas of emphasis include 1) educating and training health-care providers who insert and maintain catheters; 2) using maximal sterile barrier precautions during central venous catheter insertion; 3) using a 2% chlorhexidine preparation for skin antisepsis; 4) avoiding routine replacement of central venous catheters as a strategy to prevent infection; and 5) using antiseptic/antibiotic impregnated short-term central venous catheters if the rate of infection is high despite adherence to other strategies (i.e., education and training, maximal sterile barrier precautions, and 2% chlorhexidine for skin antisepsis). These guidelines also identify performance indicators that can be used locally by health-care institutions or organizations to monitor their success in implementing these evidence-based recommendations.

show abstract

Evaluation of Outcome of Intravenous Catheter-related Infections in Critically Ill Patients

Cited by 316 publications

References 18 publications

Morbidity and Mortality of Bloodstream Infections in Patients With Severe Burn Injury

Morbidity and Mortality of Bloodstream Infections in Patients With Severe Burn Injury

The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation

Guidelines for the prevention of intravascular catheter-related infections

Contact Info

Product

Resources

About